GLP1R and obesity due to melanocortin 4 receptor deficiency: Furthermore, research continues to highlight the benefits of GLP-1 medications on health conditions outside of type 2 diabetes and overweight and obesity, such as polycystic ovarian syndrome (PCOS), endometriosis [22], and infertility [23].